Advances in prognostic models for osteosarcoma risk
被引:2
|
作者:
Yao, Yi
论文数: 0引用数: 0
h-index: 0
机构:
Guangxi Med Univ, Guangxi Engn Ctr Biomed Mat Tissue & Organ Regene, Affiliated Hosp 1, Nanning 530021, Peoples R China
Guangxi Med Univ, Affiliated Hosp 1, Collaborat Innovat Ctr Regenerat Med & Med Bioreso, Nanning 530021, Peoples R ChinaGuangxi Med Univ, Guangxi Engn Ctr Biomed Mat Tissue & Organ Regene, Affiliated Hosp 1, Nanning 530021, Peoples R China
Yao, Yi
[1
,2
]
Wang, Dapeng
论文数: 0引用数: 0
h-index: 0
机构:
Guangxi Med Univ, Guangxi Engn Ctr Biomed Mat Tissue & Organ Regene, Affiliated Hosp 1, Nanning 530021, Peoples R ChinaGuangxi Med Univ, Guangxi Engn Ctr Biomed Mat Tissue & Organ Regene, Affiliated Hosp 1, Nanning 530021, Peoples R China
Wang, Dapeng
[1
]
Zheng, Li
论文数: 0引用数: 0
h-index: 0
机构:
Guangxi Med Univ, Guangxi Engn Ctr Biomed Mat Tissue & Organ Regene, Affiliated Hosp 1, Nanning 530021, Peoples R China
Guangxi Med Univ, Affiliated Hosp 1, Collaborat Innovat Ctr Regenerat Med & Med Bioreso, Nanning 530021, Peoples R China
Guangxi Med Univ, Life Sci Inst, Nanning 530021, Peoples R ChinaGuangxi Med Univ, Guangxi Engn Ctr Biomed Mat Tissue & Organ Regene, Affiliated Hosp 1, Nanning 530021, Peoples R China
Zheng, Li
[1
,2
,4
]
Zhao, Jinmin
论文数: 0引用数: 0
h-index: 0
机构:
Guangxi Med Univ, Guangxi Engn Ctr Biomed Mat Tissue & Organ Regene, Affiliated Hosp 1, Nanning 530021, Peoples R China
Guangxi Med Univ, Affiliated Hosp 1, Collaborat Innovat Ctr Regenerat Med & Med Bioreso, Nanning 530021, Peoples R China
Guangxi Med Univ, Dept Orthoped, Affiliated Hosp 1, Nanning 530021, Peoples R ChinaGuangxi Med Univ, Guangxi Engn Ctr Biomed Mat Tissue & Organ Regene, Affiliated Hosp 1, Nanning 530021, Peoples R China
Zhao, Jinmin
[1
,2
,3
]
Tan, Manli
论文数: 0引用数: 0
h-index: 0
机构:
Guangxi Med Univ, Guangxi Engn Ctr Biomed Mat Tissue & Organ Regene, Affiliated Hosp 1, Nanning 530021, Peoples R China
Guangxi Med Univ, Affiliated Hosp 1, Collaborat Innovat Ctr Regenerat Med & Med Bioreso, Nanning 530021, Peoples R China
Guangxi Med Univ, Life Sci Inst, Nanning 530021, Peoples R ChinaGuangxi Med Univ, Guangxi Engn Ctr Biomed Mat Tissue & Organ Regene, Affiliated Hosp 1, Nanning 530021, Peoples R China
Tan, Manli
[1
,2
,4
]
机构:
[1] Guangxi Med Univ, Guangxi Engn Ctr Biomed Mat Tissue & Organ Regene, Affiliated Hosp 1, Nanning 530021, Peoples R China
[2] Guangxi Med Univ, Affiliated Hosp 1, Collaborat Innovat Ctr Regenerat Med & Med Bioreso, Nanning 530021, Peoples R China
[3] Guangxi Med Univ, Dept Orthoped, Affiliated Hosp 1, Nanning 530021, Peoples R China
[4] Guangxi Med Univ, Life Sci Inst, Nanning 530021, Peoples R China
The risk prognosis model is a statistical model that uses a set of features to predict whether an individual will develop a specific disease or clinical outcome. It can be used in clinical practice to stratify disease severity and assess risk or prognosis. With the advancement of large-scale secondgeneration sequencing technology, along Prognosis models for osteosarcoma are increasingly being developed as large-scale second-generation sequencing technology advances and clinical and biological data becomes more abundant. This expansion greatly increases the number of prognostic models and candidate genes suitable for clinical use. This article will present the predictive effects and reliability of various prognosis models, serving as a reference for their evaluation and application.